stoxline Quote Chart Rank Option Currency Glossary
  
Assertio Holdings, Inc. (ASRT)
1.07  0.02 (1.9%)    06-18 11:47
Open: 1.03
High: 1.07
Volume: 192,263
  
Pre. Close: 1.05
Low: 1.02
Market Cap: 102(M)
Technical analysis
2024-06-18 11:18:19 AM
Short term     
Mid term     
Targets 6-month :  1.31 1-year :  1.53
Resists First :  1.12 Second :  1.31
Pivot price 1.01
Supports First :  0.99 Second :  0.92
MAs MA(5) :  1.04 MA(20) :  1.01
MA(100) :  0.93 MA(250) :  1.98
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  64.1 D(3) :  61.4
RSI RSI(14): 55.8
52-week High :  6.3 Low :  0.73
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ASRT ] has closed below upper band by 26.5%. Bollinger Bands are 14.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.05 - 1.06 1.06 - 1.06
Low: 0.98 - 0.98 0.98 - 0.99
Close: 1.04 - 1.05 1.05 - 1.06
Company Description

Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate acute pain; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.

Headline News

Sat, 15 Jun 2024
Jeff L. Vacirca Acquires 10000 Shares of Assertio Holdings, Inc. (NASDAQ:ASRT) Stock - Defense World

Thu, 13 Jun 2024
Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying - Assertio Holdings (NASDAQ:ASRT) - Benzinga

Wed, 12 Jun 2024
Assertio Holdings, Inc. (NASDAQ:ASRT) Director Purchases $11,100.00 in Stock - MarketBeat

Wed, 12 Jun 2024
Assertio Holdings director buys $11,100 in company stock By Investing.com - Investing.com

Tue, 11 Jun 2024
Possible Signal As Assertio Holdings Insiders Sell US$1.1m In Stock - Simply Wall St

Sat, 08 Jun 2024
Heather L. Mason Acquires 25000 Shares of Assertio Holdings, Inc. (NASDAQ:ASRT) Stock - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 95 (M)
Shares Float 84 (M)
Held by Insiders 2.4 (%)
Held by Institutions 49.5 (%)
Shares Short 10,730 (K)
Shares Short P.Month 10,760 (K)
Stock Financials
EPS -4.66
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.4
Profit Margin -234.4 %
Operating Margin -11.2 %
Return on Assets (ttm) 1.3 %
Return on Equity (ttm) -172.9 %
Qtrly Rev. Growth -23.7 %
Gross Profit (p.s.) 0
Sales Per Share 1.49
EBITDA (p.s.) 0.36
Qtrly Earnings Growth 0 %
Operating Cash Flow 34 (M)
Levered Free Cash Flow 13 (M)
Stock Valuations
PE Ratio -0.23
PEG Ratio -0.3
Price to Book value 0.75
Price to Sales 0.7
Price to Cash Flow 2.93
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android